awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30251738-51AEC03F-D74F-4586-B145-1DBF39724831
Q30251738-51AEC03F-D74F-4586-B145-1DBF39724831
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30251738-51AEC03F-D74F-4586-B145-1DBF39724831
Translating neoadjuvant therapy into survival benefits: one size does not fit all.
P2860
Q30251738-51AEC03F-D74F-4586-B145-1DBF39724831
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30251738-51AEC03F-D74F-4586-B145-1DBF39724831
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
73343e46a64dcf79922f7c22fafbcdf0ef965016
P2860
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized